Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoCart vs Microfracture for Knee Cartilage Repair
NCT01066702Phase 3Terminated
- Sponsor
- Histogenics
- Start
- May 2010
- Primary completion
- Mar 2019
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 2
01
Overview
A Phase 3 trial of NeoCart in Articular cartilage defect, sponsored by Histogenics. Started May 2010; status: terminated.
02
Drugs
NeoCart
03
Conditions
Articular cartilage defect
Beyond the preview
Go deeper on NCT01066702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066702.